Credit Suisse’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-53,368
Closed -$325K 4770
2021
Q3
$325K Buy
53,368
+6,051
+13% +$37.7K ﹤0.01% 4053
2021
Q2
$389K Sell
47,317
-6,872
-13% -$58.4K ﹤0.01% 3987
2021
Q1
$485K Sell
54,189
-47,263
-47% -$542K ﹤0.01% 3786
2020
Q4
$1.17M Sell
101,452
-13,580
-12% -$158K ﹤0.01% 3232
2020
Q3
$1.2M Sell
115,032
-17,931
-13% -$220K ﹤0.01% 2799
2020
Q2
$1.75M Buy
132,963
+89,105
+203% +$924K ﹤0.01% 2492
2020
Q1
$345K Sell
43,858
-9,584
-18% -$144K ﹤0.01% 3336
2019
Q4
$1.11M Sell
53,442
-38,689
-42% -$652K ﹤0.01% 3048
2019
Q3
$1.26M Buy
92,131
+17,297
+23% +$205K ﹤0.01% 2840
2019
Q2
$920K Buy
74,834
+43,550
+139% +$502K ﹤0.01% 2998
2019
Q1
$391K Buy
31,284
+4,048
+15% +$54.1K ﹤0.01% 3469
2018
Q4
$308K Buy
27,236
+4,182
+18% +$65.6K ﹤0.01% 3503
2018
Q3
$431K Sell
23,054
-8,457
-27% -$194K ﹤0.01% 3380
2018
Q2
$814K Sell
31,511
-1,631
-5% -$42.3K ﹤0.01% 3164
2018
Q1
$743K Buy
33,142
+1,029
+3% +$25.1K ﹤0.01% 3153
2017
Q4
$804K Sell
32,113
-2,495
-7% -$61.1K ﹤0.01% 3150
2017
Q3
$837K Sell
34,608
-3,191
-8% -$75K ﹤0.01% 3225
2017
Q2
$765K Sell
37,799
-378
-1% -$7.87K ﹤0.01% 2866
2017
Q1
$1.03M Buy
38,177
+19,948
+109% +$407K ﹤0.01% 2846
2016
Q4
$347K Buy
18,229
+3,465
+23% +$66.2K ﹤0.01% 3595
2016
Q3
$289K Sell
14,764
-2,906
-16% -$49.2K ﹤0.01% 3668
2016
Q2
$264K Buy
17,670
+4,814
+37% +$60.5K ﹤0.01% 3749
2016
Q1
$118K Buy
+12,856
New +$156K ﹤0.01% 3802
2015
Q4
Sell
-10,226
Closed -$152K 4412
2015
Q3
$152K Sell
10,226
-2,656
-21% -$62.3K ﹤0.01% 4016
2015
Q2
$282K Buy
+12,882
New +$260K ﹤0.01% 4050
2014
Q2
Sell
-10,074
Closed -$166K 4856
2014
Q1
$166K Buy
+10,074
New +$174K ﹤0.01% 4412